SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001159036-22-000026
Filing Date
2022-03-25
Accepted
2022-03-25 16:31:24
Documents
9
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A halodefproxy2022.htm DEF 14A 768028
2 GRAPHIC boardtenurea.jpg GRAPHIC 23848
3 GRAPHIC ceocharta.jpg GRAPHIC 24304
4 GRAPHIC halologobwa09.jpg GRAPHIC 38428
5 GRAPHIC htsignaturea10a.jpg GRAPHIC 31598
6 GRAPHIC markssignaturea.jpg GRAPHIC 4200
7 GRAPHIC otherneoa.jpg GRAPHIC 24028
8 GRAPHIC scantoa.jpg GRAPHIC 18196
9 GRAPHIC slide1b05a.jpg GRAPHIC 52580
  Complete submission text file 0001159036-22-000026.txt   1031863
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32335 | Film No.: 22771860
SIC: 2836 Biological Products, (No Diagnostic Substances)